When is follow-up after cancer treatment recommended for cervical dysplasia?

Cervical dysplasia, also called CIN, describes abnormal cells on the cervix and is not the same as invasive cervical cancer. After treatment, follow-up may include an HPV test, cervical cytology, or colposcopy. The exact schedule depends on the original result, treatment margins, test findings, and local clinical guidance.

A positive HPV result or abnormal follow-up sample does not by itself prove that cancer is present. It signals that the cervix needs the next recommended assessment, which may include closer surveillance or another colposcopy.

Keep the appointment even if you feel well, because cervical dysplasia often causes no noticeable symptoms. Take your treatment report and ask which test is planned, when results are expected, and how the result changes the next appointment.

Tell the clinic if you are pregnant, recently gave birth, immunocompromised, or unable to attend on the planned date. Do not assume a routine screening invitation replaces surveillance arranged after treatment.

Contact a clinician promptly for bleeding after sex, bleeding between periods, unusual persistent discharge, pelvic pain, or bleeding after a cervical procedure. Seek urgent help for heavy bleeding, severe pain, fainting, or fever. These symptoms need assessment and should not wait for routine surveillance.

What grade of dysplasia was treated? Which follow-up test do I need, and when? What result would lead to colposcopy or further treatment?